David Limsui, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 4
Offices
4 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Limsui’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A110121 · Current
Licensed to practise in California · since 2009 · expires 2027-09-30 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$53,975
Medicare paid this office $53,975 for 256 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 52 | $9,697 | $186 |
| Return visit (30+ min) | 48 | $7,109 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $5,024 | $239 |
| Biopsy of large bowel using a flexible endoscope | 34 | $4,554 | $134 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,091 | $117 |
See all 10 services
| New patient visit (60+ min) | 52 | $9,697 | $186 |
| Return visit (30+ min) | 48 | $7,109 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $5,024 | $239 |
| Biopsy of large bowel using a flexible endoscope | 34 | $4,554 | $134 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,091 | $117 |
| Long return visit (40+ min) | 19 | $3,609 | $172 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,945 | $97 |
| Biopsy of large bowel using a flexible endoscope | 11 | $1,696 | $154 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,251 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,062 | $71 |
Procedures Medicare counted
| Colonoscopy | 60 | More than 67% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 38 | More than 59% of doctors who do this |
Who their Medicare patients are
256 Original Medicare patients in 2024. Average age 72 · Under 65 13% · 85 and older 10% · Women 53% · Also on Medicaid 28% · Health risk score 1.68. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 69% · Coronary heart disease 30% · Diabetes 29% · Chronic kidney disease 24% · Cancer 21% · Depression 19% · Atrial fibrillation 18% · COPD 16% · Heart failure 15% · Stroke 11% · Dementia 10%.
The office billed $453,545, Medicare allowed $68,245 and paid $53,975; for 379 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 256 | 379 | 72 | 1.68 | $453,545 | $53,975 |
| 2023 | 261 | 428 | 73 | 1.93 | $472,181 | $55,157 |
| 2022 | 228 | 366 | 72 | 1.91 | $405,144 | $47,873 |
| 2021 | 206 | 332 | 72 | 1.87 | $355,201 | $40,578 |
| 2020 | 119 | 183 | 71 | 1.49 | $201,122 | $21,525 |
| 2019 | 239 | 424 | 70 | 1.93 | $378,532 | $48,120 |
| 2018 | 176 | 285 | 69 | 1.63 | $310,210 | $32,627 |
| 2017 | 174 | 320 | 69 | 1.97 | $258,614 | $30,304 |
| 2016 | 210 | 358 | 68 | 1.57 | $373,205 | $37,332 |
| 2015 | 235 | 410 | 70 | 1.81 | $342,104 | $46,138 |
| 2014 | 199 | 349 | 71 | 2.17 | $184,969 | $41,150 |
| 2013 | 240 | 430 | 68 | 2.15 | $233,273 | $52,822 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 26 | $6,248 | $240 |
| Biopsy of large bowel using a flexible endoscope | 43 | $5,568 | $129 |
| Long return visit (40+ min) | 33 | $5,413 | $139 |
| New patient visit (60+ min) | 33 | $4,758 | $144 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,663 | $120 |
| Return visit (30+ min) | 38 | $4,579 | $102 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,953 | $211 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $2,116 | $73 |
| New patient visit (45+ min) | 15 | $1,987 | $132 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,985 | $90 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,359 | $105 |
| Telehealth originating site facility fee | 15 | $359 | $22 |
2022: 9 services
| Biopsy of large bowel using a flexible endoscope | 43 | $6,524 | $152 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $4,457 | $235 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,961 | $124 |
| New patient visit (60+ min) | 22 | $3,503 | $159 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,414 | $228 |
| Long return visit (40+ min) | 22 | $3,373 | $120 |
| Return visit (30+ min) | 29 | $2,896 | $80 |
| New patient visit (45+ min) | 30 | $2,863 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,115 | $88 |
2021: 7 services
| Return visit (30+ min) | 51 | $5,068 | $83 |
| Biopsy of large bowel using a flexible endoscope | 31 | $4,956 | $160 |
| New patient visit (45+ min) | 41 | $4,597 | $112 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,273 | $237 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,884 | $125 |
| Long return visit (40+ min) | 21 | $2,829 | $129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,338 | $94 |
2020: 6 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $4,346 | $229 |
| Long return visit (40+ min) | 29 | $2,558 | $83 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,088 | $116 |
| Return visit (30+ min) | 28 | $2,073 | $63 |
| New patient visit (60+ min) | 12 | $1,726 | $144 |
| New patient visit (45+ min) | 11 | $1,263 | $115 |
2019: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $4,424 | $233 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,221 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,056 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,960 | $124 |
| Long return visit (40+ min) | 34 | $3,555 | $94 |
| Biopsy of large bowel using a flexible endoscope | 27 | $2,898 | $107 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,848 | $105 |
| New patient visit (60+ min) | 17 | $2,588 | $152 |
| New patient visit (45+ min) | 24 | $2,544 | $106 |
| Return visit (30+ min) | 30 | $2,500 | $68 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,437 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,254 | $66 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $93 | $5 |
2018: 7 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 22 | $5,388 | $234 |
| Biopsy of large bowel using a flexible endoscope | 36 | $5,316 | $148 |
| Return visit (30+ min) | 41 | $3,648 | $65 |
| New patient visit (45+ min) | 30 | $2,911 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,223 | $117 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,003 | $91 |
| Long return visit (40+ min) | 14 | $1,397 | $100 |
2017: 10 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,638 | $122 |
| New patient visit (45+ min) | 33 | $3,465 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $3,045 | $65 |
| Return visit (30+ min) | 38 | $2,909 | $63 |
| Biopsy of large bowel using a flexible endoscope | 16 | $2,140 | $134 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,310 | $94 |
| Long return visit (40+ min) | 13 | $1,295 | $100 |
| Biopsy of large bowel using a flexible endoscope | 11 | $1,184 | $108 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,079 | $98 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 20 | $110 | $5 |
2016: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 24 | $5,569 | $232 |
| Biopsy of large bowel using a flexible endoscope | 44 | $5,470 | $119 |
| New patient visit (45+ min) | 35 | $3,312 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,129 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,701 | $64 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,695 | $100 |
| Return visit (30+ min) | 33 | $2,376 | $61 |
| Return visit (30+ min) | 21 | $1,681 | $60 |
| New patient visit (45+ min) | 13 | $1,319 | $101 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,180 | $107 |
2015: 9 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 56 | $6,708 | $118 |
| New patient visit (45+ min) | 48 | $5,428 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 43 | $4,510 | $105 |
| Return visit (30+ min) | 52 | $4,418 | $70 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $4,251 | $266 |
| Biopsy of large bowel using a flexible endoscope | 27 | $4,101 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,500 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,558 | $111 |
| Return visit (30+ min) | 14 | $834 | $60 |
2014: 8 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $7,584 | $110 |
| Return visit (30+ min) | 35 | $5,384 | $79 |
| Biopsy of large bowel using a flexible endoscope | 29 | $5,365 | $185 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,876 | $98 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $3,608 | $100 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,731 | $248 |
| Insertion of stomach tube using a flexible endoscope | 11 | $1,906 | $173 |
| New patient visit (45+ min) | 14 | $1,765 | $126 |
2013: 8 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 90 | $10,090 | $107 |
| Biopsy of large bowel using a flexible endoscope | 39 | $6,406 | $164 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | $6,142 | $114 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $5,119 | $107 |
| Return visit (30+ min) | 44 | $4,700 | $77 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,313 | $240 |
| New patient visit (45+ min) | 34 | $3,896 | $115 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $3,130 | $165 |
Medicaid work
$1,426 in 2024
Medicaid paid $1,426 for 27 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 12 | $1,386 |
| Injection, propofol, 10 mg | 15 | $40 |
| 2024 | 27 | 2 | 12 | $1,426 |
| 2018 | 25 | 2 | 13 | $503 |
See the largest Medicaid services in earlier years
2018
| TISSUE EXAM BY PATHOLOGIST | 13 | $405 |
| Injection, propofol, 10 mg | 12 | $98 |
Drugs they prescribed that Part D paid
$1,218,693
Pharmacies billed $1,218,693 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 435) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
314 generic and 121 brand-name prescriptions · $1,218,693 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Stelara | 26 | $731,039 | $28,117 |
| Mesalamine | 27 | $17,897 | $663 |
| Peg 3350-Electrolyte | 59 | $1,349 | $23 |
| Sulfasalazine | 12 | $950 | $79 |
| Gavilyte-G | 39 | $620 | $16 |
See all 9 drugs
| Stelara | 26 | $731,039 | $28,117 |
| Mesalamine | 27 | $17,897 | $663 |
| Peg 3350-Electrolyte | 59 | $1,349 | $23 |
| Sulfasalazine | 12 | $950 | $79 |
| Gavilyte-G | 39 | $620 | $16 |
| Pantoprazole | 21 | $578 | $28 |
| Peg-3350 and Electrolytes | 19 | $296 | $16 |
| Omeprazole | 51 | $257 | $5 |
| Famotidine | 15 | $52 | $3 |
Year by year
| 2024 | 435 | 198 | 0% (0) | 28% | $1,218,693 |
| 2023 | 416 | 173 | 0% (0) | 24% | $881,434 |
| 2022 | 480 | 195 | 0% (0) | 31% | $713,671 |
| 2021 | 282 | 124 | 0% (0) | 43% | $268,864 |
| 2020 | 248 | 75 | 0% (0) | 41% | $323,370 |
| 2019 | 219 | 112 | 0% (0) | 29% | $163,444 |
| 2018 | 227 | 120 | 0% (0) | 48% | $414,680 |
| 2017 | 139 | 46 | 0% (0) | 55% | $191,097 |
| 2016 | 257 | 85 | 0% (0) | None | $254,999 |
| 2015 | 259 | 87 | 0% (0) | None | $127,516 |
| 2014 | 190 | 45 | 0% (0) | None | $103,370 |
| 2013 | 151 | 52 | None | None | $20,071 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Humira(Cf) | 16 | $262,924 | $16,433 |
| Mesalamine | 23 | $12,665 | $551 |
| Mesalamine Er | 25 | $10,256 | $410 |
| Peg 3350-Electrolyte | 85 | $1,921 | $23 |
| Sulfasalazine | 14 | $1,079 | $77 |
| Omeprazole | 55 | $733 | $13 |
| Pantoprazole | 17 | $654 | $38 |
| Baclofen | 15 | $501 | $33 |
| Gavilyte-G | 26 | $487 | $19 |
| Mirtazapine | 13 | $109 | $8 |
2022: 12 drugs
| Stelara | 13 | $324,069 | $24,928 |
| Humira | 12 | $165,848 | $13,821 |
| Humira(Cf) | 11 | $152,301 | $13,846 |
| Mesalamine Er | 27 | $17,095 | $633 |
| Mesalamine | 22 | $7,861 | $357 |
| Dexilant | 12 | $3,836 | $320 |
| Peg 3350-Electrolyte | 116 | $2,311 | $20 |
| Omeprazole | 48 | $589 | $12 |
| Dicyclomine | 14 | $422 | $30 |
| Pantoprazole | 20 | $368 | $18 |
| Baclofen | 12 | $338 | $28 |
| Gavilyte-C | 11 | $194 | $18 |
2021: 8 drugs
| Humira(Cf) | 11 | $138,658 | $12,605 |
| Mesalamine Er | 24 | $13,493 | $562 |
| Mesalamine | 21 | $8,615 | $410 |
| Suprep | 24 | $2,611 | $109 |
| Omeprazole | 32 | $561 | $18 |
| Pantoprazole | 19 | $537 | $28 |
| Peg 3350-Electrolyte | 37 | $442 | $12 |
| Gavilyte-G | 11 | $141 | $13 |
2020: 6 drugs
| Humira(Cf) | 24 | $123,319 | $5,138 |
| Mesalamine | 30 | $16,797 | $560 |
| Mesalamine Er | 19 | $10,534 | $554 |
| Gavilyte-G | 23 | $304 | $13 |
| Pantoprazole | 14 | $250 | $18 |
| Omeprazole | 18 | $175 | $10 |
2019: 7 drugs
| Humira(Cf) | 17 | $115,135 | $6,773 |
| Lansoprazole | 11 | $12,156 | $1,105 |
| Gavilyte-G | 33 | $478 | $14 |
| Omeprazole | 33 | $385 | $12 |
| Gavilyte-N | 14 | $286 | $20 |
| Peg 3350-Electrolyte | 16 | $272 | $17 |
| Pantoprazole | 16 | $243 | $15 |
2018: 7 drugs
| Humira | 11 | $108,538 | $9,867 |
| Humira | 13 | $64,192 | $4,938 |
| Sulfasalazine Dr | 14 | $905 | $65 |
| Peg 3350-Electrolyte | 33 | $564 | $17 |
| Gavilyte-N | 22 | $421 | $19 |
| Gavilyte-G | 16 | $230 | $14 |
| Pantoprazole | 16 | $191 | $12 |
2017: 4 drugs
| Humira | 12 | $107,247 | $8,937 |
| Apriso | 16 | $7,064 | $442 |
| Peg 3350-Electrolyte | 17 | $277 | $16 |
| Pantoprazole | 19 | $152 | $8 |
2016: 8 drugs
| Cimzia | 14 | $99,235 | $7,088 |
| Canasa | 11 | $9,787 | $890 |
| Dexilant | 16 | $5,791 | $362 |
| Pantoprazole | 20 | $422 | $21 |
| Gavilyte-N | 14 | $251 | $18 |
| Peg 3350-Electrolyte | 12 | $208 | $17 |
| Omeprazole | 15 | $207 | $14 |
| Baclofen | 11 | $140 | $13 |
2015: 8 drugs
| Cimzia | 12 | $71,838 | $5,987 |
| Canasa | 14 | $12,003 | $857 |
| Apriso | 16 | $6,310 | $394 |
| Cholestyramine Light | 14 | $877 | $63 |
| Peg 3350-Electrolyte | 24 | $440 | $18 |
| Omeprazole | 26 | $270 | $10 |
| Polyethylene Glycol 3350 | 11 | $152 | $14 |
| Dicyclomine | 16 | $100 | $6 |
2014: 7 drugs
| Humira | 12 | $37,306 | $3,109 |
| Apriso | 15 | $5,134 | $342 |
| Dexilant | 13 | $3,705 | $285 |
| Mercaptopurine | 11 | $1,111 | $101 |
| Omeprazole | 38 | $673 | $18 |
| Gavilyte-G | 12 | $176 | $15 |
| Dicyclomine | 17 | $111 | $7 |
2013: 3 drugs
| Omeprazole | 45 | $857 | $19 |
| Peg-3350 and Electrolytes | 12 | $190 | $16 |
| Dicyclomine | 12 | $101 | $8 |
Money from drug and device companies
$52 in 2025
| 2025 | 2 | 2 | None | $52 |
| 2024 | 1 | 3 | None | $153 |
| 2022 | 1 | 1 | None | $118 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $27 | 1 payment
|
| Boston Scientific | General - Gi Dilatation | $25 | 1 payment
|
See all 2 published payments
| Janssen Biotech | Meals · 2025-11-10 | Tremfya | $27 |
| Boston Scientific | Meals · 2025-05-09 | General - Gi Dilatation | $25 |
See earlier years (2024, 2022)
2024: $153
| Boston Scientific | Resolution 360 Ultra Clip | $153 | 3 payments
|
2022: $118
| Abbvie | Rinvoq | $118 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1568449650
- Licence
- CA A110121, MN 47712California A110121: Current · expires 2027-09-30
- Trained
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb), 2004
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- MN 400002100
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2005-12-29
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 420 Broadway St Fl D2, Redwood City, CA, 94063 · 430 Broadway St Fl C3, Redwood City, CA, 94063